Search
Search Results
-
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
785PDF: 2256Supplementary: 300Appendix: 249 -
Lipoprotein(a): what clinicians need to know
214PDF: 513HTML: 23 -
The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysis
2334PDF: 642Conflict of interest: 318SUPPLEMENTARY MATERIAL: 252HTML: 39 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
734PDF: 181Supplementary: 145Appendix: 104HTML: 18 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
725PDF: 196Supplementary: 140Appendix: 109HTML: 20 -
Modulation of cardiac metabolism in heart failure
2311PDF: 1131HTML: 19 -
The association of iron deficiency with right ventricular dysfunction in Africans with heart failure
2221PDF: 382Appendix B: 427Appendix A: 318HTML: 2 -
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
121PDF: 204Supplementary: 142HTML: 16 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1050pdf: 233Supplementary Material: 38HTML: 99 -
-
Evolving targets for heart failure: the journey so far
1964pdf: 303HTML: 4 -
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
1860PDF: 503SUPPLEMENTARY MATERIAL: 295GRAPHICAL ABSTRACT: 261HTML: 9 -
Safety and efficacy of left atrial appendage closure in cancer versus non-cancer patients: a systematic review and meta-analysis
1084PDF: 250Supplementary: 154HTML: 78

